These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6470874)

  • 1. Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children.
    Odio C; McCracken GH; Nelson JD
    J Pediatr; 1984 Sep; 105(3):491-3. PubMed ID: 6470874
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin/aminoglycoside nephrotoxicity.
    Dean RP; Wagner DJ; Tolpin MD
    J Pediatr; 1985 May; 106(5):861-2. PubMed ID: 3998936
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
    Nahata MC
    Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
    Rybak MJ; Albrecht LM; Boike SC; Chandrasekar PH
    J Antimicrob Chemother; 1990 Apr; 25(4):679-87. PubMed ID: 2351627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
    Malacarne P; Bergamasco S; Donadio C
    Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of vancomycin in patients with normal serum creatinine.
    Colares VS; Oliveira RB; Abdulkader RC
    Nephrol Dial Transplant; 2006 Dec; 21(12):3608. PubMed ID: 16861241
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.
    Le J; Ny P; Capparelli E; Lane J; Ngu B; Muus R; Romanowski G; Vo T; Bradley J
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e109-16. PubMed ID: 26582878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review.
    Wu CY; Wang JS; Chiou YH; Chen CY; Su YT
    Ren Fail; 2007; 29(8):1059-61. PubMed ID: 18067058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
    Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
    Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive toxicity in patients receiving vancomycin and aminoglycosides.
    Rybak MJ; Boike SC
    Clin Pharm; 1983; 2(6):508. PubMed ID: 6653052
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of aminoglycoside-induced nephrotoxicity in cystic fibrosis.
    Schofield DH; Mangione RA; Kay BG; Gorvoy JD
    Drug Intell Clin Pharm; 1984 Feb; 18(2):153-5. PubMed ID: 6697878
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.
    Cimino MA; Rotstein C; Slaughter RL; Emrich LJ
    Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
    McKamy S; Hernandez E; Jahng M; Moriwaki T; Deveikis A; Le J
    J Pediatr; 2011 Mar; 158(3):422-6. PubMed ID: 20888013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubular disorders in low birth weight neonates after prolonged antibiotic treatment.
    Giapros VI; Papadimitriou FK; Andronikou SK
    Neonatology; 2007; 91(2):140-4. PubMed ID: 17344665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.
    Krcméry V; Fuchsberger P; Gocár M; Salát T; Bodnárová J; Sobota R; Koza I; Svec J
    Chemotherapy; 1991; 37(4):287-91. PubMed ID: 1790727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older.
    Wang Y; Dai N; Wei W; Jiang C
    Clin Interv Aging; 2021; 16():1023-1035. PubMed ID: 34103905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside nephrotoxicity and creatinine clearance.
    Moss AH; Whittier FC
    Ann Intern Med; 1984 Jul; 101(1):143-4. PubMed ID: 6732080
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of aminoglycosides during cyclosporine A immunosuppression after liver transplantation in children.
    Leach CT; Kuhls TL; Brill JE; Busuttil RW; Cherry JD
    Pediatr Infect Dis J; 1989 Jun; 8(6):354-7. PubMed ID: 2664691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between vancomycin-associated nephrotoxicity and the number of combined nephrotoxic agents.
    Ueki T; Sanematsu E; Furuya Y; Shinohara Y; Murakami Y; Miyazaki A; Sakamoto Y; Nakashima MN; Nakashima M
    Pharmazie; 2020 Jun; 75(6):279-283. PubMed ID: 32539926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.